ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
(MM)

(MM) (QCOR)

93.60
0.00
(0.00%)
At close: March 28 04:00PM
93.60
0.00
( 0.00% )

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
93.60
Bid
0.00
Ask
0.00
Volume
0.00
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
93.60
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

QCOR Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
QLIQilian International Holding Group Ltd
$ 1.05
(52.20%)
2.85M
SBFMSunshine Biopharma Inc
$ 0.08
(32.23%)
26.19M
GRTXGalera Therapeutics Inc
$ 0.1731
(23.64%)
1.26M
MEDPMedpace Holdings Inc
$ 480.00
(18.77%)
1.41k
JSPRWJasper Therapeutics Inc
$ 0.2147
(17.97%)
600
XTKGX3 Holdings Company Ltd
$ 0.646
(-34.75%)
1.33M
VVOSVivos Therapeutics Inc
$ 3.60
(-25.47%)
86.98k
NVVENuvve Holding Corporation
$ 0.8625
(-21.59%)
138.49k
NDRAENDRA Life Sciences Inc
$ 0.4782
(-17.55%)
151.76k
XPONExpion360 Inc
$ 2.63
(-15.71%)
21.85k
SBFMSunshine Biopharma Inc
$ 0.08
(32.23%)
26.19M
CRKNCrown Electrokinetics Corporation
$ 0.0606
(1.17%)
7.37M
AAPLApple Inc
$ 171.28
(-0.12%)
3.57M
JAGXJaguar Health Inc
$ 0.0865
(-3.78%)
3.52M
GMDAGamida Cell Ltd
$ 0.0384
(6.37%)
3.39M

QCOR Discussion

View Posts
protagonist12 protagonist12 10 years ago
Selloff down to the teens due to Achtar dropped coverage fiasco 2 years ago, and nice climb back up to 90s thanks to Andrew Left and Citron Research. He'll have a tough time thrashing Achtar now that its owned by Mallinckrodt behemoth. But the short squeeze on this stock with over 100% institutional ownership was sorta weird.
πŸ‘οΈ0
elbiatcho1 elbiatcho1 10 years ago
Mallinckrodt Completes Acquisition Of Questcor Pharmaceuticals

- Creates a diversified, high-growth therapeutic portfolio, capable of delivering substantial, sustainable value for shareholders- Significantly increases Mallinckrodt's scale, revenues, profitability and cash flow- Expected to be immediately accretive to Mallinckrodt's fiscal 2014 adjusted diluted earnings per share; significantly accretive to adjusted diluted earnings per share in fiscal 2015

DUBLIN, Aug. 14, 2014 /PRNewswire/ -- Mallinckrodt plc MNK +1.82% , a leading global specialty pharmaceutical company, today announced that it has completed its acquisition of Questcor Pharmaceuticals, Inc. QCOR +1.65% in a cash and stock transaction valued at approximately $5.8 billion. The acquisition is expected to be immediately accretive to Mallinckrodt's fiscal 2014 adjusted diluted earnings per share and significantly accretive to its adjusted diluted earnings per share in fiscal 2015.

The merger follows strong approval by both Mallinckrodt and Questcor shareholders at separate special meetings held today. Under the terms of the merger agreement, Questcor shareholders will receive $30.00 in cash and 0.897 of a Mallinckrodt ordinary share for each Questcor share.

"We are pleased to complete this transformative transaction and believe it will provide a strong, durable, well-diversified and sustainable platform, capable of generating significant future revenue and earnings growth for Mallinckrodt shareholders," said Mark Trudeau, President and Chief Executive Officer of Mallinckrodt. "HP Acthar® Gel has demonstrated success in treating patients suffering from a variety of devastating and difficult-to-treat autoimmune and inflammatory illnesses. We are confident that Acthar will be a strong complement to Mallinckrodt's broadening portfolio of leading specialty pharmaceutical brands, and we look forward to leveraging our extensive manufacturing and scientific expertise, as well as our experience with advocacy and payer communities, to capitalize on the many opportunities it presents."

Mr. Trudeau added, "We are very pleased to welcome the Questcor team to Mallinckrodt. We are excited about our future prospects and the benefits that our collective efforts will have for patients, our investors and the communities that we serve."

As previously disclosed, commercial operations supporting HP Acthar Gel will function as a separate business within Mallinckrodt's Specialty Pharmaceuticals segment reporting to Mr. Trudeau. It will be known as the Autoimmune and Rare Diseases business within Mallinckrodt.
...
http://www.marketwatch.com/story/mallinckrodt-completes-acquisition-of-questcor-pharmaceuticals-2014-08-14

Its done. Maybe see ya on the other side.
πŸ‘οΈ0
stocktrademan stocktrademan 10 years ago
Questcor Pharmaceuticals, Inc. [$QCOR] due diligence

bullish short squeeze

$QCOR

DD Notes ~ http://www.ddnotesmaker.com/QCOR

##### recent news/filings ~ source: finance.yahoo.com

Mon, 30 Jun 2014 22:07:14 GMT ~ Questcor And Mallinckrodt: The Good, The Bad, And The Ugly
read full: http://seekingalpha.com/article/2293805-questcor-and-mallinckrodt-the-good-the-bad-and-the-ugly?source=yahoo
*********************************************************

Mon, 30 Jun 2014 15:53:00 GMT ~ Hey Mallinckrodt, Pay Close Attention - UnitedHealth Just Slammed Questcor's Acthar
read full: http://seekingalpha.com/article/2292885-hey-mallinckrodt-pay-close-attention-unitedhealth-just-slammed-questcors-acthar?source=yahoo
*********************************************************

Thu, 26 Jun 2014 21:47:01 GMT ~ Why Small-Cap Stocks ARRIS and Questcor Have Huge Growth Potential
read full: http://www.fool.com/investing/general/2014/06/26/why-small-cap-stocks-arris-and-questcor-have-huge.aspx?source=eogyholnk0000001
*********************************************************

Wed, 25 Jun 2014 17:49:25 GMT ~ The FDA Owes Us An Answer On Questcor's Acthar
read full: http://seekingalpha.com/article/2286053-the-fda-owes-us-an-answer-on-questcors-acthar?source=yahoo
*********************************************************

Mon, 23 Jun 2014 13:00:00 GMT ~ Questcor Pharmaceuticals Closes Transaction to Acquire International Rights to Synacthen® and Synacthen® Depot
[PR Newswire] - ANAHEIM, Calif., June 23, 2014 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (QCOR) today announced that the transaction acquiring rights to Synacthen® and Synacthen® Depot from Novartis Pharma AG and Novartis AG in certain countries outside the U.S. has now closed. Available in more than forty countries for multiple indications, Synacthen (tetracosactide) is a synthetic 24 amino acid melanocortin peptide. Synacthen Depot is a depot formulation of Synacthen. The products are approved outside the U.S. for multiple indications, including certain autoimmune and inflammatory conditions as well as for diagnostic use, but have never been developed or approved for patients in the U.S. Questcor is presently engaged in pre-clinical development for Synacthen in the U.S. "As a leader in melanocortin peptide therapeutics, we now have the opportunity with Synacthen to expand our commercial presence to more than forty international markets, and develop a new potential platform for international growth in this important emerging field of medicine," said Steve Cartt, Chief Operating Officer of Questcor.
read full: http://finance.yahoo.com/news/questcor-pharmaceuticals-closes-transaction-acquire-130000695.html
*********************************************************

##### chart ~ source: stockcharts.com



##### chart ~ source: eoddata.com



##### company info ~ source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/QCOR/company-info
Ticker: $QCOR
OTC Market Place: Not Available
CIK code: 0000891288
Company name: Questcor Pharmaceuticals, Inc.
Company website: http://www.questcor.com
Incorporated In: CA, USA

##### extra dd links

Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000891288&owner=exclude&count=40
Latest filings: http://www.otcmarkets.com/stock/QCOR/filings
Latest financials: http://www.otcmarkets.com/stock/QCOR/financials
Latest news: http://www.otcmarkets.com/stock/QCOR/news - http://finance.yahoo.com/q/h?s=QCOR+Headlines

Major holdings: http://data.cnbc.com/quotes/QCOR/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=QCOR+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/QCOR.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=QCOR

RegSho: http://www.regsho.com/tools/symbol_stats.php?sym=QCOR&search=search

DTCC: http://search2.dtcc.com/?q=Questcor+Pharmaceuticals%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&q=Questcor+Pharmaceuticals%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results?term=Questcor+Pharmaceuticals%2C+Inc.&x=0&y=0
WHOIS: http://whois.domaintools.com/http://www.questcor.com
Alexa: http://www.alexa.com/siteinfo/http://www.questcor.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.questcor.com

Short Sales: http://www.otcmarkets.com/stock/QCOR/short-sales
Insider Disclosure: http://www.otcmarkets.com/stock/QCOR/insider-transactions
Research Reports: http://www.otcmarkets.com/stock/QCOR/research
Historical Prices: http://finance.yahoo.com/q/hp?s=QCOR+Historical+Prices
Basic Tech. Analysis: http://finance.yahoo.com/q/ta?s=QCOR+Basic+Tech.+Analysis
Company Profile: http://finance.yahoo.com/q/pr?s=QCOR+Profile
Key Statistics: http://finance.yahoo.com/q/ks?s=QCOR+Key+Statistics
Industry: http://finance.yahoo.com/q/in?s=QCOR+Industry
Insider Roster: http://finance.yahoo.com/q/ir?s=QCOR+Insider+Roster
Income Statement: http://finance.yahoo.com/q/is?s=QCOR
Balance Sheet: http://finance.yahoo.com/q/bs?s=QCOR
Cash Flow: http://finance.yahoo.com/q/cf?s=QCOR+Cash+Flow&annual
Market Watch: http://www.marketwatch.com/investing/stock/QCOR
Bloomberg: http://www.bloomberg.com/quote/QCOR:US
Morningstar: http://quotes.morningstar.com/stock/s?t=QCOR
Bussinessweek: http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=QCOR
Barchart: http://www.barchart.com/quotes/stocks/QCOR
OTC Short Report: http://otcshortreport.com/index.php?index=QCOR
Investopedia: http://www.investopedia.com/markets/stocks/QCOR/?wa=0

http://www.pennystocktweets.com/stocks/profile/QCOR

##### last known share structure ~ source: otcmarkets.com

Market Value: $5,639,764,117 a/o
Shares Outstanding: 60,977,015 a/o Mar 31, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value

##### business description ~ source: otcmarkets.com



DD Notes ~ http://www.ddnotesmaker.com/QCOR

πŸ‘οΈ0
elbiatcho1 elbiatcho1 10 years ago
That's a nice bonus, sheesh.

ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.

On May 13, 2014, Questcor Pharmaceuticals, Inc. (the β€œCompany”) entered into an amendment (the β€œAsarpota Amendment”) to the severance agreement with Rajesh Asarpota, the Company’s Senior Vice President, Chief Financial Officer. Under the Asarpota Amendment, if the proposed merger with Mallinckrodt plc and Quincy Merger Sub, Inc. is consummated and an excise tax is imposed on Mr. Asarpota as a result of any compensation or benefits provided to Mr. Asarpota in connection with the consummation of the proposed merger, the Company will pay or reimburse Mr. Asarpota an amount equal to such excise tax plus any taxes resulting from such payment or reimbursement.
πŸ‘οΈ0
elbiatcho1 elbiatcho1 10 years ago
Old news from February.

Citron has been attacking QCOR for a long time and is probably involved in the major shorting activity that has hit the stock repeatedly.

That new article from the "analyst firm" is simply a lawyer shopping for invidivuals who feel they've been deceived.
πŸ‘οΈ0
investorguy84 investorguy84 10 years ago
Looks like an analyst firm issued a couple of reports on the company's acthar drug. A law firm wrote a blog article that looks like they picked up on this analyst report.

insert-text-here

insert-text-here

insert-text-here


I'm not sure what to think about this. Any thoughts? This seems like a pretty damaging report.

πŸ‘οΈ0
stockmavin stockmavin 10 years ago
You are right. They all seem to be jumping onto the bandwagon now.
πŸ‘οΈ0
Topgun21 Topgun21 10 years ago
Congrats QCOR on your Buyout! Nicely Done!!


Regards,
Tim
πŸ‘οΈ0
elbiatcho1 elbiatcho1 10 years ago
There is almost always an investigation whenever any company sells out/merges.

I don't think this has anything to do with shorts.

Just typical lawyers looking for some income using the usual lingo:
The investigation focuses on whether Questcor's Board of Directors breached their fiduciary duties to the Company's stockholders by failing to conduct a fair sales process and whether and by how much this proposed transaction undervalues the Company to the detriment of Questcor's shareholders.
πŸ‘οΈ0
stockmavin stockmavin 10 years ago
"Faruqi & Faruqi, LLP Announces the Investigation of Questcor Pharmaceuticals Inc. (QCOR) Over the Proposed Sale of the Company to Mallinckrodt plc"

Sounds like the shorts are upset on their big losses. imo
πŸ‘οΈ0
stockmavin stockmavin 10 years ago
So glad they get what they deserve!
πŸ‘οΈ0
elbiatcho1 elbiatcho1 10 years ago
80-100? Lmao.
Rather amazing when poster was spot on?... although it took a couple more years.
πŸ‘οΈ0
Joe89 Joe89 10 years ago
Congrats on the buyout QCOR shareholders!
πŸ‘οΈ0
elbiatcho1 elbiatcho1 10 years ago
Twas a nice run everyone.
Congrats to the longs, been in it since 1.25.
πŸ‘οΈ0
FairviewInvestor FairviewInvestor 10 years ago
and the shorts get crushed...
πŸ‘οΈ0
StickyStock StickyStock 10 years ago
Nice Roth pick here
πŸ‘οΈ0
Wallstreetcounter Wallstreetcounter 10 years ago
New report out Wallstreetcounterpoint.com on QCOR
πŸ‘οΈ0
stockmavin stockmavin 10 years ago
smh...Universal Commodity Corporation
πŸ‘οΈ0
Rawnoc Rawnoc 10 years ago
QCOR -- just shorted at $57.335 average based on this report and tons before it:

http://www.citronresearch.com/wp-content/uploads/2013/12/QCOR1203-update-final.pdf
πŸ‘οΈ0
ECole ECole 10 years ago
Interesting presentation at Credit-Suisse-Healthcare-Conference


http://www.earningsimpact.com/Transcript/84507/QCOR/2013-Credit-Suisse-Healthcare-Conference
πŸ‘οΈ0
ECole ECole 11 years ago
Q2 2013, 177 million of Acthar sales, up 57% from the prior period.

Call transcript
http://www.earningsimpact.com/Transcript/82494/QCOR/Q2-2013-Earnings-Call
πŸ‘οΈ0
elbiatcho1 elbiatcho1 11 years ago
Seems like a huge jump in sales.
Net sales for the second quarter ended June 30, 2013 were $184.6 million, up 64% from $112.5 million in the second quarter of 2012.
http://ih.advfn.com/p.php?pid=nmona&article=58610511&symbol=QCOR

No wonder big a/h spike.
πŸ‘οΈ0
mkinhaw mkinhaw 11 years ago
New all time hi 59.00 a/h s

wow

MK
πŸ‘οΈ0
SilverSurfer SilverSurfer 11 years ago
bullish consolidation after breakout

πŸ‘οΈ0
TheFinalCD TheFinalCD 11 years ago
wow nice sell right at the T.O.P
πŸ‘οΈ0
deadboy deadboy 11 years ago
Got in today, hope the party isn't over
πŸ‘οΈ0
MARINO MARINO 11 years ago
DBEN out at $46.45
πŸ‘οΈ0
The Night Stalker The Night Stalker 11 years ago
was in this at 1.50 in 2007,, sold for 2.50 and now it creeps up big many years late.
πŸ‘οΈ0
MARINO MARINO 11 years ago
And we are UP !
πŸ‘οΈ0
TheFinalCD TheFinalCD 11 years ago
Big NEWS,
πŸ‘οΈ0
MARINO MARINO 11 years ago
Yep and with excellent news
πŸ‘οΈ0
TheFinalCD TheFinalCD 11 years ago
wow opened HOD $50 and closed LOD
πŸ‘οΈ0
MARINO MARINO 11 years ago
DBEN in at $42
πŸ‘οΈ0
protagonist12 protagonist12 11 years ago
Yeah strange AH dip on blowout earnings. A similar thing happened after 2012 Q4 earnings report. QCOR blew away analysts EPS forcasts by .30 a share and yet the thing traded sideways for months.

You have to wonder why this stock has been in a holding pattern for 6 over months, but I guess there are still questions as to whether or not Achtar will be covered by major policies such as Aetna. Gee I wonder if Andrew Left and Citron Research is still shorting this.
πŸ‘οΈ0
investingdog investingdog 11 years ago
Unusual AH trading after the earnings. Record April sales lifted the stock after the initial drop. It will be interesting tomorrow.
πŸ‘οΈ0
stockmavin stockmavin 11 years ago
Nice results. Beat the street estimate and increased divi.

πŸ‘οΈ0
Its A Whiz Its A Whiz 11 years ago
Go QCOR LONG!!! big epic spike going to happen if this goes over $32, valuation $90, earnings 26th no replay of last time going to happen, shorts will be exiting the building enmass soon, Funds are buying in big. Technicals have changed to positive. Short term $45 long term $100 plus. New VP is a buyout negotiator, $$$$
πŸ‘οΈ0
Nebuchadnezzar Nebuchadnezzar 11 years ago
and $26 appears to be a crucial level

hard to see just how much accumulation is taking place, but keep an eye on $25-$26 price level in which we are currently in
πŸ‘οΈ0
Sry8 Sry8 11 years ago
Very quite in here. After days doing DD, I'm all in. Picked up @ $26.83. No debt and increasing revenue this stock has potential. Glta!
πŸ‘οΈ0
StockConsultant_com StockConsultant_com 11 years ago
QCOR continuation breakout watch above 28.6

looks like another run but could use more volume

BREAKOUT WATCH for possible breakout above 28.6, no resistance in area just above.
Type: Continuation breakout from single resistance.
Target: 32.21, 13.2% Stop: 27.33, Loss: 4%, Profit/Loss ratio: 3.3 : 1 - Excellent

CURRENT PRICE 28.46, at resistance, 27.79 ± 0.81, type single, strength 1

RESISTANCE ABOVE +23.9% at 35.27 ± 1.02, type single, strength 3
+36.2% at 38.75 ± 1.12, type double, strength 7
+42.1% at 40.44 ± 1.17, type triple, strength 5

source: http://www.stockconsultant.com/consultnow/basicplus.cgi?symbol=QCOR
πŸ‘οΈ0
stockmavin stockmavin 11 years ago
After all of these baseless class actions fail, I would love to see the company go after not only those Law firms for defamation, but also that shorter blog or website that I believe had some large monetary motive in contacting the firms.
πŸ‘οΈ0
jas1n jas1n 11 years ago
big move today and I dont see any news that would have made it go up like it did
πŸ‘οΈ0
frosr6 frosr6 11 years ago
HUGE INSIDER BUYING

Ready for a run up!!!

PURCHASED
11/5/2012 55,000 shares@ 23.92 for a total of $1,315,400!!
11/2/2012 10,000 shares@ 24.17 for a total of $241,696


http://www.secform4.com/insider-trading/891288.htm
πŸ‘οΈ0
Nebuchadnezzar Nebuchadnezzar 11 years ago
earnings did not disappoint but how about that nice call on market selling off, it's not done yet, but QCOR may still go up with positive earnings, but there are investigations/lawsuits so I honestly would be a little hesitant to continue playing with fire, that's all

there is only one stock i want to see tank and that is KCG and maybe GS

good luck to all here, hopefully nothing to serious with whatever is going on behind the scenes and may $30+ return
πŸ‘οΈ0
fafssaf fafssaf 11 years ago
QCOR beats estimates! EPS of 0.91 from an estimate of 0.75. Tomorrow should be interesting.
πŸ‘οΈ0
zephyroo zephyroo 11 years ago
been a helluva ride past couple days.
πŸ‘οΈ0
armchairboogie armchairboogie 11 years ago
Looks as if today's bear raid failed hard and fast.
πŸ‘οΈ0
shankapotamus shankapotamus 11 years ago
Look out belowwww
πŸ‘οΈ0
gixxer11 gixxer11 11 years ago
Rut ro
πŸ‘οΈ0
philca philca 11 years ago
Good start for today...
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock